thiocholchicine has been researched along with paclitaxel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colombo, F; Comi, D; Danieli, B; Ferrante, L; Paganini, G; Passarella, D; Vanossi, A; Zuco, V; Zunino, F | 1 |
| Ayoub, AT; Lopus, M; Mahaddalkar, T; Minu, M; Missiaen, K; Pasdar, M; Singh, D; Tilli, TM; Tuszynski, J; Winter, P | 1 |
| Appendino, G; Bombardelli, E; Danieli, B; Fontana, G; Giardini, A; Lesma, G; Noncovich, A; Passarella, D; Silvani, A; Sterner, O | 1 |
3 other study(ies) available for thiocholchicine and paclitaxel
| Article | Year |
|---|---|
Histone deacetylase and microtubules as targets for the synthesis of releasable conjugate compounds.
Topics: Acetylation; Antineoplastic Agents; Cell Cycle; Drug Design; Glutathione; HeLa Cells; Histone Deacetylase 2; Histone Deacetylases; Humans; Microtubule-Associated Proteins; Microtubules; Protein Processing, Post-Translational; Protein Structure, Tertiary; Structure-Activity Relationship; Tubulin | 2009 |
Chemical synthesis, pharmacological evaluation and in silico analysis of new 2,3,3a,4,5,6-hexahydrocyclopenta[c]pyrazole derivatives as potential anti-mitotic agents.
Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Cell Line, Tumor; Cyclopentanes; Drug Screening Assays, Antitumor; Humans; Ligands; Molecular Docking Simulation; Protein Structure, Tertiary; Pyrazoles; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2016 |
Synthesis and biological evaluation of paclitaxel-thiocolchicine hybrids.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cattle; Cell Line, Tumor; Colchicine; Drug Screening Assays, Antitumor; Humans; Microtubules; Paclitaxel | 2004 |